Sawai Pharmaceutical at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Sawai Pharmaceutical brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Sawai Pharmaceutical's program centres on oral solid dosage forms. Its work covers a quaternary amorphous solid dispersion of enzalutamide and the molecular interactions behind it, and coated mini-tablets that gel to make swallowing easier.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Sawai Pharmaceutical Osaka, Japan | |
Major Japanese maker of generic medicines, developing and manufacturing generic tablets and other dosage forms. | Poster Mon Oct 26 2:30pm–3:30pm Development of a Novel Quaternary Amorphous Solid Dispersion of Enzalutamide and Elucidation of the Intermolecular Interaction Network Poster Tue Oct 27 3:30pm–4:30pm Development of Novel Gelation Film-Coated Mini-Tablets for Improved Swallowability and a Robust Quality Control Strategy in Commercial Manufacturing |
Instantly find 20 buyers from Sawai Pharmaceutical
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction